CRP and metabolic syndrome: In both cohorts, participants with hepatic steatosis appeared to be older, to be more likely to be male, and to have diabetes, hypertension, dyslipidemia, elevated CRP, low eGFR, and higher BMI compared with participants without hepatic steatosis (Table 1).